GLUTAMICS—a randomized clinical trial on glutamate infusion in 861 patients undergoing surgery for acute coronary syndrome Mårten Vidlund, MD, PhD, Erik Håkanson, MD, PhD, Örjan Friberg, MD, PhD, Sören Juhl-Andersen, MD, Jonas Holm, MD, Farkas Vanky, MD, PhD, Lena Sunnermalm, MD, Jan-Olov Borg, MD, Rajiv Sharma, MD, Rolf Svedjeholm, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 144, Issue 4, Pages 922-930.e7 (October 2012) DOI: 10.1016/j.jtcvs.2012.05.066 Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions
Figure 1 Consort flow chart. The Journal of Thoracic and Cardiovascular Surgery 2012 144, 922-930.e7DOI: (10.1016/j.jtcvs.2012.05.066) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions
Figure E1 Duration of (A) intensive care unit (ICU) stay and (B) ventilator treatment in patients with left ventricular failure at weaning from cardiopulmonary bypass in the glutamate group (n = 20) or control group (n = 18). LV, Left ventricular; CPB, cardiopulmonary bypass. The Journal of Thoracic and Cardiovascular Surgery 2012 144, 922-930.e7DOI: (10.1016/j.jtcvs.2012.05.066) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions